179 related articles for article (PubMed ID: 35579154)
1. The Emerging Role of LncRNA FENDRR in Multiple Cancers: A Review.
Fazaeli H; Sheikholeslami A; Ghasemian F; Amini E; Sheykhhasan M
Curr Mol Med; 2023 May; 23(7):606-629. PubMed ID: 35579154
[TBL] [Abstract][Full Text] [Related]
2. The Therapeutic Value and Molecular Mechanisms of lncRNA FENDRR in Human Cancer.
Xu W; Wang B; Cai Y; Chen J; Meng E; Guo C; Zhou G; Yuan C
Curr Pharm Des; 2021; 27(39):4100-4106. PubMed ID: 34414867
[TBL] [Abstract][Full Text] [Related]
3. FENDRR: A pivotal, cancer-related, long non-coding RNA.
Zheng Q; Zhang Q; Yu X; He Y; Guo W
Biomed Pharmacother; 2021 May; 137():111390. PubMed ID: 33761608
[TBL] [Abstract][Full Text] [Related]
4. LncRNA FENDRR Expression Correlates with Tumor Immunogenicity.
Munteanu MC; Sethuraman SN; Singh MP; Malayer J; Ranjan A
Genes (Basel); 2021 Jun; 12(6):. PubMed ID: 34200642
[TBL] [Abstract][Full Text] [Related]
5. LncRNA FENDRR suppresses the progression of NSCLC via regulating miR-761/TIMP2 axis.
Zhang G; Wang Q; Zhang X; Ding Z; Liu R
Biomed Pharmacother; 2019 Oct; 118():109309. PubMed ID: 31545237
[TBL] [Abstract][Full Text] [Related]
6. Integrated Analysis of lncRNAs and mRNAs Identifies a Potential Driver lncRNA
Duan Y; Li WX; Wang Y; Zhao Y; Shen J; Deng CJ; Li Q; Chen R; Liu X; Zhang YL
Nutr Cancer; 2021; 73(6):983-995. PubMed ID: 32590916
[TBL] [Abstract][Full Text] [Related]
7. LncRNA FENDRR-mediated tumor suppression and tumor-immune microenvironment changes in non-small cell lung cancer.
Pan H; Yu T; Sun L; Chai W; Liu X; Yan M
Transl Cancer Res; 2020 Jun; 9(6):3946-3959. PubMed ID: 35117761
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA FENDRR inhibits NSCLC cell growth and aggressiveness by sponging miR-761.
Zhang MY; Zhang ZL; Cui HX; Wang RK; Fu L
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8324-8332. PubMed ID: 30556873
[TBL] [Abstract][Full Text] [Related]
9. LncRNA FENDRR sensitizes doxorubicin-resistance of osteosarcoma cells through down-regulating ABCB1 and ABCC1.
Kun-Peng Z; Xiao-Long M; Chun-Lin Z
Oncotarget; 2017 Sep; 8(42):71881-71893. PubMed ID: 29069754
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive Analysis of lncRNA and mRNA Expression Profiles in Lung Cancer.
Chen R; Li WX; Sun Y; Duan Y; Li Q; Zhang AX; Hu JL; Wang YM; Gao YD
Clin Lab; 2017 Feb; 63(2):313-320. PubMed ID: 28182363
[TBL] [Abstract][Full Text] [Related]
11. Decreased expression of the long non-coding RNA FENDRR is associated with poor prognosis in gastric cancer and FENDRR regulates gastric cancer cell metastasis by affecting fibronectin1 expression.
Xu TP; Huang MD; Xia R; Liu XX; Sun M; Yin L; Chen WM; Han L; Zhang EB; Kong R; De W; Shu YQ
J Hematol Oncol; 2014 Aug; 7():63. PubMed ID: 25167886
[TBL] [Abstract][Full Text] [Related]
12. Long Noncoding RNA
Senavirathna LK; Liang Y; Huang C; Yang X; Bamunuarachchi G; Xu D; Dang Q; Sivasami P; Vaddadi K; Munteanu MC; Hewawasam S; Cheresh P; Kamp DW; Liu L
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445242
[TBL] [Abstract][Full Text] [Related]
13. FENDRR Sponges miR-424-5p to Inhibit Cell Proliferation, Migration and Invasion in Colorectal Cancer.
Cheng C; Li H; Zheng J; Xu J; Gao P; Wang J
Technol Cancer Res Treat; 2020; 19():1533033820980102. PubMed ID: 33356998
[TBL] [Abstract][Full Text] [Related]
14.
Terashima M; Ishimura A; Wanna-Udom S; Suzuki T
J Biol Chem; 2018 Nov; 293(47):18016-18030. PubMed ID: 30262664
[TBL] [Abstract][Full Text] [Related]
15. The role of long non-coding RNA AFAP1-AS1 in human malignant tumors.
Ji D; Zhong X; Jiang X; Leng K; Xu Y; Li Z; Huang L; Li J; Cui Y
Pathol Res Pract; 2018 Oct; 214(10):1524-1531. PubMed ID: 30173945
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA
Zhao X; Wu J; Li Y; Ye F; Wang C
Bioengineered; 2021 Dec; 12(1):8698-8708. PubMed ID: 34697986
[TBL] [Abstract][Full Text] [Related]
17. Screening for key lncRNAs in the progression of gallbladder cancer using bioinformatics analyses.
Zhang L; Geng Z; Meng X; Meng F; Wang L
Mol Med Rep; 2018 May; 17(5):6449-6455. PubMed ID: 29512694
[TBL] [Abstract][Full Text] [Related]
18. A functional CNVR_3425.1 damping lincRNA FENDRR increases lifetime risk of lung cancer and COPD in Chinese.
Yang L; Wu D; Chen J; Chen J; Qiu F; Li Y; Liu L; Cao Y; Yang B; Zhou Y; Lu J
Carcinogenesis; 2018 Mar; 39(3):347-359. PubMed ID: 29293945
[TBL] [Abstract][Full Text] [Related]
19. LncRNA FENDRR attenuates adriamycin resistance via suppressing MDR1 expression through sponging HuR and miR-184 in chronic myelogenous leukaemia cells.
Zhang F; Ni H; Li X; Liu H; Xi T; Zheng L
FEBS Lett; 2019 Aug; 593(15):1993-2007. PubMed ID: 31180580
[TBL] [Abstract][Full Text] [Related]
20. An integrated analysis of the competing endogenous RNA network associated of prognosis of stage I lung adenocarcinoma.
Xu Y; Lin G; Liu Y; Lin X; Lin H; Guo Z; Xu Y; Lin Q; Chen S; Yang J; Zeng Y
BMC Cancer; 2022 Feb; 22(1):188. PubMed ID: 35183135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
